Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q2 CY2025, with sales up 10.3% year ...

The $3.00-a-share midpoint of its new range would put it just below the FactSet consensus estimate of $3.02 a share for Pfizer’s adjusted 2025 earnings.

Pfizer boosted its profit outlook for the year following gains to its top- and bottom-line in its latest quarter.

Stock futures edged higher on Tuesday as investors weighed a fresh batch of corporate earnings reports alongside comments on ...

Pfizer raised its full-year profit forecast on Tuesday after topping Wall Street expectations for second-quarter results as ...

Advanced Micro Devices ( AMD) shares will be under the spotlight as it reports its second-quarter results on Tuesday after ...

Pfizer raised its full-year profit forecast on Tuesday while reporting second-quarter results that topped Wall Street ...

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

Had you invested $1,000 into Pfizer's stock on Aug. 1, 2020, your investment would only be worth around $638 as of Aug. 1, ...

The final trades of the day with CNBC’s Melissa Lee and the "Fast Money" traders. 4 people who have seen the Epstein files ...